openPR Logo
Press release

Global Recombinant Hirudin Market Status & Insights Forecasted till 2022

06-30-2017 02:11 PM CET | Health & Medicine

Press release from: Market Research Hub - Pharmaceutical Industry

MRH

MRH

Recombinant hirudin is known to be a potent thrombin-specific inhibitor resulting from the natural hirudin of the leech. Over the years, the demand for this inhibitor has risen due to the rise in number of patients suffering from thrombosis disease. To cover the market status, a fresh report has been added to the wide database of Market Research Hub (MRH). The research study is titled “Global Recombinant Hirudin Market Research Report 2017”, which includes data about the key regions active in the production of recombinant hirudin. Moreover, the report also reveals growth of the sector at a double-digit CAGR during the period 2017-2022.

Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1139566

Presently, the market for recombinant hirudin is growing due to its applications in the medical sector. This medicine is needed for the treatment of tumor disease, which surges its market importance on the global level. Depending on the product variety, recombinant hirudin is available in a number of versions depending on the dosage, such as 12000 ATU / mg, 95% and 16000 ATU / mg, 95%. Furthermore, manufacturers like Abbott, Teva Pharmaceutical Industries Ltd, The Medicines Company, Pfizer, Inc and Pentapharm, contribute heavily to the development of the recombinant hirudin market.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Recombinant Hirudin in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

Global Recombinant Hirudin market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Abbott
The Medicines Company
Teva Pharmaceutical Industries Ltd
Pfizer, Inc
Pentapharm

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
12000 ATU / mg, 95%
16000 ATU / mg, 95%?
16000 ATU / mg, 98%?
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Recombinant Hirudin for each application, including
Thrombosis Disease
Tumor Disease
Others

Browse Full Report with TOC @ http://www.marketresearchhub.com/report/global-recombinant-hirudin-market-research-report-2017-report.html

Table of content:

Global Recombinant Hirudin Market Research Report 2017
1 Recombinant Hirudin Market Overview
1.1 Product Overview and Scope of Recombinant Hirudin
1.2 Recombinant Hirudin Segment by Type (Product Category)
1.2.1 Global Recombinant Hirudin Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Recombinant Hirudin Production Market Share by Type (Product Category) in 2016
1.2.3 12000 ATU / mg, 95%
1.2.4 16000 ATU / mg, 95%?
1.2.5 16000 ATU / mg, 98%?
1.2.6 Others
1.3 Global Recombinant Hirudin Segment by Application
1.3.1 Recombinant Hirudin Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Thrombosis Disease
1.3.3 Tumor Disease
1.3.4 Others
1.4 Global Recombinant Hirudin Market by Region (2012-2022)
1.4.1 Global Recombinant Hirudin Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Recombinant Hirudin (2012-2022)
1.5.1 Global Recombinant Hirudin Revenue Status and Outlook (2012-2022)
1.5.2 Global Recombinant Hirudin Capacity, Production Status and Outlook (2012-2022)

Make an Enquiry @ http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1139566

About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of Research Reports and analysis. MRH’s expansive collection of pharmaceutical market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Read More Industry News @ https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Recombinant Hirudin Market Status & Insights Forecasted till 2022 here

News-ID: 603792 • Views:

More Releases from Market Research Hub - Pharmaceutical Industry

Global Enthesopathy Treatment Market Analysis by Type, Application, Top Key Players are-Abbott Laboratories, Eli Lilly, Janssen Biotech, Pfizer, Siemens and Forecast 2019-2025
Global Enthesopathy Treatment Market Analysis by Type, Application, Top Key Play …
The global market status for Enthesopathy Treatment is precisely examined through a smart research report added to the broad database managed by Market Research Hub (MRH). This study is titled “Global Enthesopathy Treatment Market Size, Status and Forecast 2019-2025”, which tends to deliver in-depth knowledge associated to the Enthesopathy Treatment market for the present and forecasted period until 2025. Furthermore, the report examines the target market based on market size,
Global BioImaging Technologies Market Status, Growth Opportunity, Scope, Key Players:-Hologic, Hitachi, Digirad, FONAR, Covidien, Mindray and Forecast 2019-2025
Global BioImaging Technologies Market Status, Growth Opportunity, Scope, Key Pla …
The market for BioImaging Technologies is growing with the expansion of this Industry Sector Worldwide. Market Research Hub (MRH) has added a new report titled “Global BioImaging Technologies Market Size, Status and Forecast 2019-2025” which offer details about the current trends and analysis, as well as scope for the near future. This research study also covers information about the production, consumption and market share based on different active regions. Furthermore,
Global Drugs and Diagnostics for Hematological Disorders Market Report Overview 2019-2025 | Top Players are-Abbot, Pfizer, Mindray, Roche, Biorad, Siemens
Global Drugs and Diagnostics for Hematological Disorders Market Report Overview …
Market Research Hub (MRH) has actively included a new research study titled “Global Drugs and Diagnostics for Hematological Disorders Market Size, Status and Forecast 2019-2025” to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period
Global Biosimilar Testing and Development Services Market Report Overview 2019-2025 | Top Players are-Eurofins Scientific, Exova, Source BioScience, Intertek Group, Sigma-Aldrich
Global Biosimilar Testing and Development Services Market Report Overview 2019-2 …
Market Research Hub (MRH) has actively included a new research study titled “Global Biosimilar Testing and Development Services Market Size, Status and Forecast 2019-2025” to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period until

All 5 Releases


More Releases for Recombinant

Global Recombinant Vaccines Market Segmentation, Business Analysis and Forecast …
Global Recombinant Vaccines Market Analysis 2022-2028 Report provides strategists, marketers and senior management with the critical information they need to assess the global Recombinant Vaccines Market as it emerges from the Covid-19 shut down. The impact of Coronavirus (COVID-19) on global market has reinforced many trends already shaping the industry pre COVID-19, There is a long-term trend towards the repositioning of players as entertainment providers on multiple platforms. This study provides
Recombinant Protein Market Size, Share | Recombinant Protein Industry Future Gro …
Global Recombinant Protein Market Report provides a detailed industry overview along with the analysis of Cost Structure, Supply Chain, Development Techniques, Retailers Analysis, Financial Support, business Strategies, Marketing Channels. Global Recombinant Protein Market research report provides a point-by-pointIn-Depth analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations,
Human Recombinant Insulin Market Growth Analysis
"Industry analysis is a crucial step in the current competitive market space that helps identify the right target customers and accordingly provide tailored solutions for their business needs. Every aspect and unique challenges put up by the particular industry are carefully taken into consideration while formulating these solutions. It also takes into consideration various government reforms, competitive environment, customer behavior, existing and upcoming business models, and ever-evolving technological developments. Industry
United States Recombinant Vaccine Market Report
In this report, the United States Recombinant Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share
Recombinant Proteins Market 2022 | Recombinant Proteins Market: Global Industry …
Recombinant proteins play an imperative role in treating various diseases, such as hemophilia. Majority of the recombinant proteins used are human proteins, in order to compensate the functional proteins in vivo defects by increasing the protein function in a body. This Research Report Insights analyzes the expansion of global recombinant protein market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022. The next
Recombinant DNA Technology Market -
Recombinant DNA technology has allowed the transfer of desired characteristics which is useful to improve the existing systems by controlling expression of target genes. Recombinant DNA technology allows mass production of therapeutic proteins, which are characterized by high level of consistency and stability. The technology has multidisciplinary applications and potential to deal with important aspects of life, for instance, improving health, and enhancing food resources. The genetically modified plants have